NCT01991314 Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate Status COMPLETED Phase PHASE4
NCT01988506 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Status COMPLETED Phase PHASE2
NCT01966744 Self-Management Assistance for Recommended Treatment (SMART) Portal Status COMPLETED Phase N/A
NCT01961492 Fecal Microbiota Transplantation in Patients With Ulcerative Colitis Status WITHDRAWN Phase NA
NCT01959165 MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients Status COMPLETED Phase PHASE2
NCT01947101 Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children Status COMPLETED Phase PHASE1
NCT01941589 Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis Status COMPLETED Phase PHASE4
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01929668 Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients Status COMPLETED Phase NA
NCT01916161 The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients Status COMPLETED Phase N/A
NCT01914887 Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis Status UNKNOWN Phase PHASE1/PHASE2
NCT01891214 Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase N/A
NCT01882764 HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis Status TERMINATED Phase PHASE3
NCT01882205 Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis Status RECRUITING Phase NA
NCT01861288 Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease Status COMPLETED Phase N/A